<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Barnet 1D PCN</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
            in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
            mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
            population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
        </p>
        <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
            it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
        </p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=pcn+U84655">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
            send short or detailed feedback.
        </p>
        <h2>Prescribing where Barnet 1D PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0803041U0&amp;denomIds=8.3.4&amp;selectedTab=summary">Toremifene citrate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Breast cancer</td>
      <td>643</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>13.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0803041U0AAAAAA&amp;denomIds=8.3.4&amp;selectedTab=summary" target="_blank">Toremifene 60mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0202040H0&amp;denomIds=2.2.4&amp;selectedTab=summary">Co-triamterzide(Triamterene/hydrochlorothiazide)</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Potassium sparing diuretics and compounds</td>
      <td>57</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>11.51</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0202040H0AAAAAA&amp;denomIds=2.2.4&amp;selectedTab=summary" target="_blank">Co-triamterzide 50mg/25mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1003020AD&amp;denomIds=10.3.2&amp;selectedTab=summary">Arnica montana</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>2391</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>11.15</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1003020ADAAAAAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Arnica montana gel : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1003020ADBBAAAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Atrogel Arnica gel : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0408010D0&amp;denomIds=4.8.1&amp;selectedTab=summary">Oxcarbazepine</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>194</td>
      <td>Control of epilepsy</td>
      <td>7780</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>5.88</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0408010D0AAABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Oxcarbazepine 300mg tablets : 165</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0408010D0AAACAC&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Oxcarbazepine 150mg tablets : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0408010D0AAADAD&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Oxcarbazepine 600mg tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0408010D0AAAEAE&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Oxcarbazepine 60mg/ml oral suspension sugar free : 9</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0408010D0BBADAE&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Trileptal 60mg/ml oral suspension : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1309000F0&amp;denomIds=13.9&amp;selectedTab=summary">Alkyl sulfate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Shampoos and some other scalp preparations</td>
      <td>482</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>5.56</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1309000F0BBAAAA&amp;denomIds=13.9&amp;selectedTab=summary" target="_blank">Dentinox Cradle Cap treatment shampoo : 10</a></div></td></tr></tbody></table>

        <h2>Prescribing where Barnet 1D PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0301030S0&amp;denomIds=3.1.3&amp;selectedTab=summary">Theophylline</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>49</td>
      <td>Theophylline</td>
      <td>195</td>
      <td>0.25</td>
      <td>0.84</td>
      <td>0.15</td>
      <td>-3.96</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0301030S0AAAMAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Theophylline 200mg modified-release tablets : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0301030S0BKABAM&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 200mg tablets : 43</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0301030S0BKACAP&amp;denomIds=3.1.3&amp;selectedTab=summary" target="_blank">Uniphyllin Continus 300mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0105020A0&amp;denomIds=1.5.2&amp;selectedTab=summary">Budesonide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Corticosteroids</td>
      <td>15</td>
      <td>0.20</td>
      <td>0.72</td>
      <td>0.18</td>
      <td>-2.82</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0105020A0AAACAC&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 3mg gastro-resistant capsules : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0105020A0AAADAD&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 2mg foam enema : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0309010C0&amp;denomIds=3.9.1&amp;selectedTab=summary">Codeine phosphate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>8</td>
      <td>Cough suppressants</td>
      <td>37</td>
      <td>0.22</td>
      <td>0.78</td>
      <td>0.21</td>
      <td>-2.68</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0309010C0AAAAAA&amp;denomIds=3.9.1&amp;selectedTab=summary" target="_blank">Codeine 15mg/5ml linctus : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0309010C0AAADAD&amp;denomIds=3.9.1&amp;selectedTab=summary" target="_blank">Codeine 15mg/5ml linctus sugar free : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0&amp;denomIds=4.7.2&amp;selectedTab=summary">Morphine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>345</td>
      <td>Opioid analgesics</td>
      <td>3810</td>
      <td>0.09</td>
      <td>0.21</td>
      <td>0.06</td>
      <td>-2.19</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AAA6A6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 20mg/ml oral solution sugar free : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/1ml solution for injection ampoules : 30</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AAADAD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 30mg/1ml solution for injection ampoules : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AAAIAI&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 60mg modified-release tablets : 9</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AAAKAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release tablets : 31</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AAALAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release tablets : 19</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AACFCF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 15mg modified-release tablets : 15</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AACGCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 5mg modified-release tablets : 23</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AACNCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine sulfate 10mg/5ml oral solution : 98</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AAEFEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 10mg modified-release capsules : 13</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0AAEGEG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Morphine 30mg modified-release capsules : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BBAAAK&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 10mg tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BBABAL&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 30mg tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BBAEAG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 200mg tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BBAKCG&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">MST Continus 5mg tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BCABA6&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 20mg/ml concentrated oral solution : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BCAGCN&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Oramorph 10mg/5ml oral solution : 66</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BHACCD&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 10mg tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BHADCE&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Sevredol 20mg tablets : 4</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BKAAEF&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 10mg modified-release capsules : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=0407020Q0BKACEH&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Zomorph 60mg modified-release capsules : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0&amp;denomIds=13.4&amp;selectedTab=summary">Betamethasone valerate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>580</td>
      <td>Topical corticosteroids</td>
      <td>3141</td>
      <td>0.18</td>
      <td>0.28</td>
      <td>0.04</td>
      <td>-2.18</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AAAAAA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% cream : 47</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AAABAB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.025% cream : 29</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AABABA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% ointment : 33</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AABBBB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.025% ointment : 19</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AABCBC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% lotion : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AABDBD&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% scalp application : 150</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AABFBF&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone 0.1% foam : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AACBCB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% / Neomycin 0.5% cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0AACCCC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betamethasone valerate 0.1% / Fusidic acid 2% cream : 148</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BBAAAA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate 0.1% cream : 70</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BBADAB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate RD 0.025% cream : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BBAEBA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate 0.1% ointment : 6</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BBAHBB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate RD 0.025% ointment : 12</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BBAJBD&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betnovate 0.1% scalp application : 9</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BCABCC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Fucibet cream : 23</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BCACCC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Fucibet Lipid cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BDAABD&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Betacap 0.1% scalp application : 8</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U84655&amp;numIds=1304000F0BGABBA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Audavate 0.1% ointment : 16</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>